Hei Bang Shunyi real estate

Beijing Tongrentang was once again punished by informed criticism for violating regulations.

A few days ago (July 26th), Beijing Medical Insurance Bureau issued the Notice on the Decision on Handling Violations of Four Designated Medical Institutions, including Beijing Sunshine Aibo Hospital, Beijing Shunyi District Hospital, Beijing North Hongqi Electromechanical Co., Ltd. Hospital and Beijing Tongrentang Hospital of Traditional Chinese Medicine, which showed that the violations of four designated medical institutions led to the loss of medical insurance funds, which caused adverse effects in society and damaged the image of designated medical institutions.

It is worth noting that Beijing Tongrentang Hospital of Traditional Chinese Medicine was punished by informed criticism due to the lack of relevant records in some treatment projects, and the illegal expenses were recovered.

The Health Bureau also noted that Beijing Tongrentang Group released information about this violation in official website yesterday (August 1). Tong Ren Tang said that the problems mentioned in the circular were discovered during the two inspections of 20 18 and 12 in Beijing Dongcheng District Medical Insurance Center, including: some treatment items were not recorded.

Beijing Tongrentang Hospital of Traditional Chinese Medicine immediately carried out rectification work after finding problems. From 2065438 to May 2009, Beijing Tongrentang Hospital of Traditional Chinese Medicine did not violate the rules in the "Special Action against Fraud and Insurance Fraud" carried out by Beijing Dongcheng District Medical Insurance Center, and the implementation of the problems mentioned in the circular was recognized by the competent authorities.

Beijing Municipal Medical Insurance Bureau requires all designated medical institutions in the city to take a warning, strictly implement the rules and regulations of medical insurance, conscientiously fulfill the basic medical insurance service agreement, cherish the honor of designated medical institutions, and put an end to violations.

As a designated medical institution, Tongrentang has no relevant records of treatment projects. What will this mean? What kind of punishment can I accept?

According to the Measures for the Agreement Management of Designated Medical Institutions of Beijing Basic Medical Insurance (Trial), designated medical institutions should do a good job in the medical treatment management, drug purchase management, medical treatment project and service facilities management, drug management, information management and cost management of the insured in accordance with the service agreement, and declare medical expenses to the medical insurance agency in accordance with the regulations.

In case of violation of the service agreement, the medical insurance agency will take measures such as informed criticism, yellow card warning, suspension and termination of the agreement. , and announced to the public, credited to the social insurance credit system.

According to the Health Bureau, this special action will focus on three aspects:

According to the unified deployment of Beijing, this special action will further crack down on illegal and fraudulent behaviors in the field of medical insurance, strengthen the supervision of medical insurance funds, compact the supervision responsibility, plug the loopholes in the system, and consolidate the high-pressure situation of cracking down on fraudulent insurance.

In fact, in recent years, Beijing Tongrentang has experienced frequent incidents and is experiencing a crisis of confidence.

20 19 In February, Binhai County Market Supervision Bureau of Yancheng City, Jiangsu Province and Daxing District Food and Drug Administration of Beijing announced the results of administrative punishment on the same day, and found that Tongrentang Bee Industry used recycled honey as raw material to produce honey and marked the false production date, fined140,000 yuan and confiscated 3,300 bottles of honey.

On February 19, the State Administration of Market Supervision revoked the title of China Quality Award of Beijing Tongrentang (Group) Company and withdrew the certificate and trophy. It is generally believed in the industry that although "Honey Gate" has little impact on the company's revenue and profit, it exposes the risk of loopholes in Tongrentang's product quality control and subsidiary management, and the impact goes far beyond finance.

At the same time, Tongrentang also frequently broke out product quality problems. In recent years, it has been notified by the regulatory authorities for many times because of unqualified products. In just 20 16 a year, Tongrentang was "named" six times because of quality problems, involving Potentilla discolor, Jiawei Zuojin Pill, Radix Rehmanniae Preparata, Rhizoma Drynariae (cooked) and other varieties.

In 20 17, China Food and Drug Administration * * * published a list of 22 unqualified Chinese herbal pieces, and Tongrentang ranked second with 14 times, among which the Chinese herbal pieces produced by Beijing Tongrentang (Bozhou) Pieces Co., Ltd. were on the "black list" five times.

At the end of 20 18, the State Food and Drug Administration issued a notice again, and 63 batches of licorice (licorice tablets) produced by enterprises such as Beijing Tongrentang were exposed to be unqualified.

According to incomplete statistics, Tongrentang has been on the quality "black list" for 23 times in the last three years. Some analysts pointed out that Tongrentang, as a century-old brand, should cherish the brand and cherish its wings. Once the trust of consumers is really lost, the advantages of old brands will be gradually overdrawn.